SEARCH

SEARCH BY CITATION

References

  • 1
    Smiley JD: Psoriatic arthritis. Bull Rheum Dis 44: 12, 1995
  • 2
    Willkens RF, Williams HJ, Ward JR, Egger MJ, Reading JC, Clements PJ, Cathcart ES, Samuelson CO Jr, Solsky MA, Kaplan SB, Guttadauria M, Halla JT, Weinstein A: Randomized, double-blind, placebo-controlled trial of low-dose pulse methotrexate in psoriatic arthritis. Arthritis Rheum 27: 376381, 1984
  • 3
    Dorwart BB, Gall EP, Schumacher HR, Krauser RE: Chrysotherapy in psoriatic arthritis: efficacy and toxicity compared to rheumatoid arthritis. Arthritis Rheum 21: 513515, 1978
  • 4
    Carette S, Calin A, McCafferty JP, Wallin BA, and the Auranofin Cooperating Group: A double-blind placebo-controlled study of auranofin in patients with psoriatic arthritis. Arthritis Rheum 32: 158165, 1989
  • 5
    Farr M, Kitas GD, Waterhouse L, Jubb R, Felix-Davies D, Bacon PA: Treatment of psoriatic arthritis with sulphasalazine: a one year open study. Clin Rheumatol 7: 372377, 1988
  • 6
    Newman ED, Perruquet JL, Harrington TM: Sulfasalazine therapy in psoriatic arthritis: clinical and immunologic response. J Rheumatol 18: 379382, 1991
  • 7
    Farr M, Kitas GD, Waterhouse L, Jubb R, Felix-Davies D, Bacon PA: Sulphasalazine in psoriatic arthritis: a double-blind placebo-controlled study. Br J Rheumatol 29: 4649, 1990
  • 8
    Fraser SM, Hopkins R, Hunter JA, Neumann V, Capell HA, Bird HA: Sulphasalazine in the management of psoriatic arthritis. Br J Rheumatol 32: 923925, 1993
  • 9
    Gupta AK, Grober JS, Hamilton TA, Ellis CN, Siegel MT, Voorhees JJ, McCune WJ: Sulfasalazine therapy for psoriatic arthritis: a double blind, placebo controlled trial. J Rheumatol 22: 894898, 1995
  • 10
    Dougados M, van der Linden S, Leirisalo-Repo M, Huitfeldt B, Juhlin R, Veys E, Zeidler H, Kvien TK, Olivieri I, Dijkmans B, Bertouch J, Brooks P, Edmonds J, Major G, Amor B, Calin A: Sulfasalazine in the treatment of spondylarthropathy: a randomized, multicenter, double-blind, placebo-controlled study. Arthritis Rheum 38: 618627, 1995
  • 11
    Clegg DO, Reda DJ, Weisman MH, Blackburn WD, Cush JJ, Cannon GW, Mahowald ML, Schumacher HR Jr, Taylor T, Budiman-Mak E, Cohen MR, Vasey FB, Luggen ME, Mejias E, Silverman SL, Makkena R, Alepa FP, Buxbaum J, Haakenson CM, Ward RH, Manaster BJ, Anderson RJ, Ward JR, Henderson WG: Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis: a Department of Veterans Affairs cooperative study. Arthritis Rheum 39: 20042012, 1996
  • 12
    Diggle P, Liang K, Zeger S: Analysis of Longitudinal Data. Oxford, Clarendon Press, 1994
  • 13
    SAS Institute, Inc.: SAS Technical Report P-229, SAS/STAT: Changes and Enhancements, Release 6.07. Cary, NC, SAS Institute Inc., 1992
  • 14
    Hedeker D, Gibbons RD: A random-effects ordinal regression model for multilevel analysis. Biometrics 50: 933944, 1994
  • 15
    SAS Institute, Inc.: SAS/STAT User's Guide: Version 6. Fourth edition. Cary, NC, SAS Institute, 1990